Altfest L J & CO Inc Sarepta Therapeutics, Inc. Transaction History

Altfest L J & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$113.33 - $163.85 $86,130 - $124,526	-760 Reduced 28.24%	1,931 $305,000
Q1 2024 Apr 22, 2024	BUY	$93.7 - $141.53 $252,146 - $380,857	2,691 New	2,691 $348,000
Q4 2021 Jan 24, 2022	SELL	$77.28 - $99.42 $290,572 - $373,819	-3,760 Closed	0 $0
Q3 2021 Oct 12, 2021	BUY	$65.97 - $92.48 $1,913 - $2,681	29 Added 0.78%	3,760 $348,000
Q2 2021 Jul 28, 2021	BUY	$69.38 - $86.75 $1,526 - $1,908	22 Added 0.59%	3,731 $290,000
Q1 2021 May 07, 2021	BUY	$72.25 - $168.95 $66,903 - $156,447	926 Added 33.27%	3,709 $276,000
Q4 2020 Jan 21, 2021	BUY	$125.56 - $178.74 $102,331 - $145,673	815 Added 41.41%	2,783 $474,000
Q3 2020 Oct 29, 2020	BUY	$127.12 - $172.34 $250,172 - $339,165	1,968 New	1,968 $276,000
Q1 2020 Apr 13, 2020	SELL	$82.38 - $131.64 $134,197 - $214,441	-1,629 Closed	0 $0
Q4 2019 Jan 06, 2020	BUY	$76.53 - $135.58 $124,667 - $220,859	1,629 New	1,629 $210,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Altfest L J & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Altfest L J & CO Inc with notifications on news.